GENOME KEY
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges.
GENOME KEY
Industry:
Artificial Intelligence Bioinformatics Health Care Machine Learning
Founded:
2020-12-05
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.genomekey.co
Total Employee:
1+
Status:
Active
Total Funding:
3.6 M USD
Current Employees Featured
Gregory Taylor Founder @ Genome Key
Founder
Founder
More informations about "Genome Key"
Transformative Diagnostics - IVD device | GenomeKey
GenomeKey awarded US$11.4M from global non-profit CARB-X GenomeKey is developing a next-generation in vitro diagnostic device that’s set to become the new standard for bacterial identification. The device will be able to detect and …See details»
Transformative diagnostics | GenomeKey
Founded in 2019, GenomeKey brought together scientists, engineers, and clinicians to build a next generation diagnostic device that would transform how we treat sepsis. We realised early on that the twin revolutions in DNA …See details»
Genome Key - Crunchbase Company Profile & Funding
Organization. Genome Key . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. GenomeKey …See details»
Meet the team - GenomeKey
Before joining GenomeKey, Sarah was a postdoc for five years at the Beatson Institute for Cancer Research, where she studied breast cancer cell metastasis, cell migration in 3D matrices and …See details»
GenomeKey Company Profile 2024: Valuation, Funding …
GenomeKey is a Private company. What is the current valuation of GenomeKey? The current valuation of GenomeKey is . What is GenomeKey’s current revenue? The current revenue for GenomeKey is . How much funding has GenomeKey …See details»
GenomeKey - Funding, Financials, Valuation & Investors
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
GenomeKey - LinkedIn
GenomeKey enables targeted Sepsis treatment in hours, rather than days. This is important because Sepsis now kills more people than cancer. It can hit anyone, of any age, and kills within hours.See details»
GenomeKey - Products, Competitors, Financials, Employees, …
GenomeKey’s innovative technology aims to accelerate diagnosis and deliver vital antibacterial susceptibility information that could take the guesswork out of treatment decisions in the first …See details»
GenomeKey awarded $11.4M to transform sepsis diagnosis and …
Jul 31, 2024 GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator to build a functioning, automated prototype of their …See details»
GenomeKey raise Innovate UK funding to drive life …
May 19, 2022 Our member GenomeKey, has secured an Innovate UK Biomedical Catalyst research award of £950,000 towards faster diagnosis and treatment of sepsis, one of the world’s most deadly diseases.. The funding will …See details»
GenomeKey - Crunchbase
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.See details»
GenomeKey case study: Saving lives through early diagnosis of …
Jul 7, 2021 GenomeKey is bringing together two transformative technologies: machine learning and whole genomic sequencing (DNA sequencing). Both of these technologies are making …See details»
GenomeKey awarded US$11.4M from global non-profit CARB-X
GenomeKey is developing a next-generation in vitro diagnostic device that’s set to become the new standard for bacterial identification. The device will be able to detect and identify bacteria …See details»
GenomeKey awarded $11.4M to transform sepsis diagnosis and …
Aug 1, 2024 GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator to build a functioning, automated prototype of their …See details»
Guidance for human genome data collection, access, use and …
Nov 20, 2024 The WHO’s new document outlines a comprehensive set of globally applicable principles designed to guide stakeholders in the responsible collection, use, and sharing of …See details»
GenomeKey - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Organization. GenomeKey . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. …See details»
Considerations in the search for epistasis - Genome Biology
Nov 19, 2024 We also thank the Artificial Intelligence Journal, the Company of Biologists, the Netherlands Organization for Scientific Research (Veni grant VI.Veni.192.043), Bielefeld …See details»
Partnerships in Diagnostics | GenomeKey
GenomeKey awarded US$11.4M from global non-profit CARB-X GenomeKey is developing a next-generation in vitro diagnostic device that’s set to become the new standard for bacterial …See details»
Parasite genome analysis provides a new approach to predicting …
1 day ago Despite considerable progress toward controlling the disease, malaria remains a leading cause of morbidity and mortality, particularly in Africa, where 95% of malaria deaths …See details»
GenomeKey - Contacts, Employees, Board Members, Advisors
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.See details»